Inflamed tissue chemokine gradient

The inflamed tissue chemokine gradient refers to the spatial distribution and concentration of chemotactic cytokines (chemokines) within a site of injury or infection [1]. This gradient is established by the secretion of chemokines from resident cells and their subsequent binding to glycosaminoglycans on the extracellular matrix and endothelial surfaces [2]. It serves as a critical directional cue for the recruitment of specific leukocyte subsets, such as neutrophils, monocytes, and T cells, from the blood into the tissue [1, 4]. In chronic inflammatory diseases and cancer, these gradients are often dysregulated, leading to persistent immune cell infiltration or the recruitment of immunosuppressive cells [3]. While not a single molecular target, the gradient is therapeutically addressed by targeting individual chemokines (e.g., CCL2, CXCL8) or their corresponding G protein-coupled receptors (e.g., CCR2, CXCR2) [2]. Disrupting these gradients can mitigate tissue damage in autoimmune conditions or prevent tumor metastasis [3, 4].

Other names

Chemokine gradientChemotactic gradientInflammatory chemokine milieuChemokine field

Disruption of directional leukocyte migration through the antagonism of chemokine receptors or the neutralization of chemokine ligands.